ABUS vs APD · P/E 5.4, rev $6.2M vs P/E 30, rev $12.04B
Arbutus Biopharma Corp (ABUS) versus Air Products and Chemicals Inc (APD) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Air Products and Chemicals Inc (APD) is a specialty chemicals company listed on NYSE.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported APD revenue for 2025-09-30 was $12.04B. Net income was -$354.4M. Revenue was down 0.5% from 2024-09-30 to 2025-09-30. APD currently screens at market cap $62.74B and trailing P/E 29.7.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. APD currently screens at market cap $62.74B and trailing P/E 29.7.
Not investment advice. Open the ABUS and APD stock pages for the full models.
Not investment advice.